Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40020810
Localisation
United States of America
Northern America
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
18/12/2025
Statut
Classification
1.5°C
Année cible
2035
Statut
Targets set
Classification
1.5°C
Année cible
2045
Overall Net-Zero Target: Navitas Parent Corporation commits to achieve net-zero greenhouse gas emissions across the value chain by 2045. Near-Term Targets: Navitas Parent Corporation commits to reduce absolute scope 1 and 2 GHG emissions 85.0% by 2030 from a 2023 base year. Navitas Parent Corporation also commits to reduce absolute scope 3 GHG emissions 40.0% by 2035 from a 2024 base year. Long-Term Targets: Navitas Parent Corporation commits to reduce absolute scope 1 and 2 GHG emissions 95.0% by 2045 from a 2024 base year. Navitas Parent Corporation also commits to reduce absolute scope 3 GHG emissions 95.0% within the same timeframe.
Statut
Targets setAnnée cible
2045
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
Source : Science Based Targets initiative | Données publiques